Disc Medicine's strong financial position, with $489.9 million in cash and securities, ensures funding through 2028, reducing near-term financing risks. Lead asset Bitopertin shows promise in treating ...
Disc Medicine, Inc. announced significant advancements in its clinical programs and financial status during the first quarter of 2025. The company is on track to submit a New Drug Application (NDA) ...
Disc Medicine announces positive updates on bitopertin, DISC-0974, and DISC-3405, with plans for upcoming clinical trials and data presentations. Disc Medicine, Inc. recently provided positive updates ...
Linux stands as a bastion of power and flexibility in the world of operating systems, particularly when it comes to managing disk storage. Whether you're a seasoned sysadmin, a developer, or a Linux ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback